Kerala Ayurveda has received a settlement order from the Securities and Exchange Board of India (SEBI), marking a significant regulatory development for the company.

Regulatory Settlement

The company has formally received the settlement order from SEBI, India's capital markets regulator. Settlement orders represent a mechanism through which regulatory matters are resolved between companies and SEBI without proceeding through the complete adjudication process.

Settlement Process

SEBI's settlement mechanism allows entities to resolve regulatory issues by agreeing to specific terms and conditions. This process typically involves the payment of settlement amounts and compliance with prescribed conditions, enabling companies to avoid prolonged regulatory proceedings.

Company Status

With the receipt of this settlement order, Kerala Ayurveda has formally concluded its regulatory matter with SEBI. The settlement represents the completion of the regulatory process between the company and the market regulator.

Kerala Ayurveda Limited has successfully concluded its postal ballot process through remote e-voting, with all three special resolutions receiving overwhelming shareholder approval on January 19, 2026. The company announced the results on January 20, 2026, demonstrating strong shareholder confidence across all proposed corporate actions.

Postal Ballot Overview

The postal ballot process was conducted in accordance with Section 110 read with Section 108 of the Companies Act, 2013, and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The e-voting period commenced on December 21, 2025, at 9:00 AM IST and concluded on January 19, 2026, at 5:00 PM IST.

Resolution Results

All three special resolutions achieved remarkable approval rates, with each resolution securing over 99.99% support from voting shareholders.

Resolution 1: Asset Charge Creation

The first resolution sought approval for creation of charge/lien over company assets under Section 180(1)(a) of the Companies Act, 2013.

Resolution 2: Investment and Loan Approvals

The second resolution covered approval for investments, providing loans, guarantees and security under Section 186 of the Companies Act, 2013.

Resolution 3: Director Re-appointment

The third resolution approved the re-appointment of Ms. Shilpa Kiran Gududur (DIN: 09067581) for a second term of five consecutive years.

Scrutinizer Report

CS Biswajit Ghosh, Designated Partner of BMP & Co. LLP, served as the appointed scrutinizer for the postal ballot process. The scrutinizer was appointed by the Board of Directors on December 17, 2025, and submitted the final report on January 20, 2026. The e-voting services were provided by Central Depository Services (India) Limited (CDSL), ensuring a transparent and secure voting process.

Shareholder Participation

The postal ballot witnessed significant participation with 4,220,164 votes polled, representing 34.99% of the company's total outstanding shares of 12,060,198. The promoter and promoter group demonstrated complete support with 100% participation and unanimous approval across all resolutions. Public non-institutional shareholders also showed strong support, with approval rates exceeding 99.86% for all three resolutions.

The successful completion of the postal ballot process strengthens Kerala Ayurveda Limited's corporate governance framework and provides the necessary approvals for strategic business operations and leadership continuity.